Cryosite Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Public

  • Employees
  • 25

Employees

  • Stock Symbol
  • CTE

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $0.46
  • (As of Wednesday Closing)

Cryosite General Information

Description

Cryosite Ltd is engaged in the provision of supply chain logistics, and management of pharmaceutical products used in clinical trials. The company's operating segment includes Cord Blood and Tissue Storage and Clinical Trials and Biological Services Logistics. It generates maximum revenue from the Clinical Trials and Biological Services Logistics segment. The clinical Trials and Biological Services Logistics segment provides specialist temperature-controlled storage, sourcing, labeling, status management, secondary packaging, scheduled drug distribution, destruction, returns, and biological services.

Contact Information

Website
www.cryosite.com
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 13a Ferndell Street South
  • Granville, New South Wales 2142
  • Australia
+61 (02)
Primary Industry
Biotechnology
Stock Exchange
ASX
Vertical(s)
Life Sciences
Corporate Office
  • 13a Ferndell Street South
  • Granville, New South Wales 2142
  • Australia
+61 (02)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cryosite Stock Performance

As of 09-Jul-2025, Cryosite’s stock price is $0.46. Its current market cap is $22.6M with 48.8M shares.

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.46 $0.48 $0.44 - $0.76 $22.6M 48.8M 6.71K $0.02

Cryosite Financials Summary

As of 31-Dec-2024, Cryosite has a trailing 12-month revenue of $8.48M.

In Thousands,
USD 		TTM 31-Dec-2024 FY 2024 30-Jun-2024 FY 2023 30-Jun-2023 FY 2022 30-Jun-2022
EV 24,474 37,934 18,786 18,064
Revenue 8,475 8,265 8,024 8,520
EBITDA 2,001 1,862 1,492 1,772
Net Income 1,208 1,206 947 988
Total Assets 11,868 13,176 14,991 14,792
Total Debt 1,466 1,634 1,725 585
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Cryosite Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Cryosite‘s full profile, request access.

Request a free trial

Cryosite Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Cryosite Ltd is engaged in the provision of supply chain logistics, and management of pharmaceutical products used in cl
Biotechnology
Granville, Australia
25 As of 2024

Moorabbin, Australia
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cryosite Competitors (1)

One of Cryosite’s competitors is Cell Care Australia, a Formerly PE-Backed company based in Moorabbin, Australia.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cell Care Australia Formerly PE-Backed Moorabbin, Australia
You’re viewing 1 of 1 competitors. Get the full list »

Cryosite Patents

  • 3

    Total Documents Applications and Grants

  • Total Patents Families

  • 1

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

Cryosite Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2001285615-A1 System and method for management of specimens Active 22-Sep-2000
AU-2001285615-B2 System and method for management of specimens Inactive 22-Sep-2000
AU-8561501-A System and method for management of specimens Pending 22-Sep-2000 G06Q10/087

Cryosite Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cryosite Acquisitions (1)

Cryosite’s most recent deal was a Merger/Acquisition with Stemlife. The deal was made on 01-Dec-2016.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Stemlife 01-Dec-2016 Merger/Acquisition Other Healthcare Services
To view Cryosite’s complete acquisitions history, request access »

Cryosite FAQs

  • When was Cryosite founded?

    Cryosite was founded in 1999.

  • Where is Cryosite headquartered?

    Cryosite is headquartered in Granville, Australia.

  • What is the size of Cryosite?

    Cryosite has 25 total employees.

  • What industry is Cryosite in?

    Cryosite’s primary industry is Biotechnology.

  • Is Cryosite a private or public company?

    Cryosite is a Public company.

  • What is Cryosite’s stock symbol?

    The ticker symbol for Cryosite is CTE.

  • What is the current stock price of Cryosite?

    As of 09-Jul-2025 the stock price of Cryosite is $0.46.

  • What is the current market cap of Cryosite?

    The current market capitalization of Cryosite is $22.6M.

  • What is Cryosite’s current revenue?

    The trailing twelve month revenue for Cryosite is $8.48M.

  • Who are Cryosite’s competitors?

    Cell Care Australia is a competitor of Cryosite.

  • What is Cryosite’s annual earnings per share (EPS)?

    Cryosite’s EPS for 12 months was $0.02.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »